Home/Filings/4/0000950170-23-071270
4//SEC Filing

Parkinson David Ross 4

Accession 0000950170-23-071270

CIK 0001633932other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 9:57 PM ET

Size

4.7 KB

Accession

0000950170-23-071270

Insider Transaction Report

Form 4
Period: 2023-12-14
Parkinson David Ross
DirectorPresident and CEO
Transactions
  • Purchase

    Common Shares

    2023-12-14$2.30/sh+9,223$21,21365,675 total
Footnotes (1)
  • [F1]The amount reflects the acquisition of shares pursuant to the ESSA Pharma Inc. Employee Stock Purchase Plan.

Documents

1 file

Issuer

ESSA Pharma Inc.

CIK 0001633932

Entity typeother

Related Parties

1
  • filerCIK 0001451935

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 9:57 PM ET
Size
4.7 KB